Cargando…
Gastric Cancer Surgery During the Pandemic: What It Costs?
BACKGROUND: From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608237/ https://www.ncbi.nlm.nih.gov/pubmed/34811648 http://dx.doi.org/10.1007/s12029-021-00751-6 |
_version_ | 1784602711901077504 |
---|---|
author | Yazici, Hilmi Eren, Ayse Uprak, Tevfik Kivilcim Sahan, Cihan Esmer, Ahmet Cem Yegen, Sevket Cumhur |
author_facet | Yazici, Hilmi Eren, Ayse Uprak, Tevfik Kivilcim Sahan, Cihan Esmer, Ahmet Cem Yegen, Sevket Cumhur |
author_sort | Yazici, Hilmi |
collection | PubMed |
description | BACKGROUND: From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment and diagnoses. Therefore, the early and long-term results may be affected during the pandemic. In this study, we aimed to evaluate pandemia effects on gastric cancer surgery in a single center. PATIENTS-METHODS: Patients were categorized as the COVID group and the Pre-COVID group. Patients who received neoadjuvant chemotherapy were excluded from the study. In the COVID period, 50 patients underwent gastric cancer surgery, while 64 were operated on in the pre-COVID period. Patients’ demographics and clinical and pathological outcomes were evaluated. RESULTS: There was no statistically significant difference in both periods among patient characteristics such as age, gender, and body mass index. Pre-operative laboratory results were similar between two groups. Although there was no difference in operation types, an increase was detected in Clavien-Dindo grade 3 and higher complications during the COVID period. During the pandemic, there was a significant difference in the pathological outcomes. Peritoneal cytology-positive patients were hıgher in the COVID group. More lymphovascular invasions were also detected in the COVID period. Finally, it resulted stage differences between two groups. CONCLUSION: Because of COVID-19’s heavy burden on healthcare system, delays in the diagnosis and treatment of oncological patients may occur. Therefore, this may be affected pathological and survival outcomes of cancer patients. Finally, further investigations are needed. |
format | Online Article Text |
id | pubmed-8608237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-86082372021-11-23 Gastric Cancer Surgery During the Pandemic: What It Costs? Yazici, Hilmi Eren, Ayse Uprak, Tevfik Kivilcim Sahan, Cihan Esmer, Ahmet Cem Yegen, Sevket Cumhur J Gastrointest Cancer Original Research BACKGROUND: From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment and diagnoses. Therefore, the early and long-term results may be affected during the pandemic. In this study, we aimed to evaluate pandemia effects on gastric cancer surgery in a single center. PATIENTS-METHODS: Patients were categorized as the COVID group and the Pre-COVID group. Patients who received neoadjuvant chemotherapy were excluded from the study. In the COVID period, 50 patients underwent gastric cancer surgery, while 64 were operated on in the pre-COVID period. Patients’ demographics and clinical and pathological outcomes were evaluated. RESULTS: There was no statistically significant difference in both periods among patient characteristics such as age, gender, and body mass index. Pre-operative laboratory results were similar between two groups. Although there was no difference in operation types, an increase was detected in Clavien-Dindo grade 3 and higher complications during the COVID period. During the pandemic, there was a significant difference in the pathological outcomes. Peritoneal cytology-positive patients were hıgher in the COVID group. More lymphovascular invasions were also detected in the COVID period. Finally, it resulted stage differences between two groups. CONCLUSION: Because of COVID-19’s heavy burden on healthcare system, delays in the diagnosis and treatment of oncological patients may occur. Therefore, this may be affected pathological and survival outcomes of cancer patients. Finally, further investigations are needed. Springer US 2021-11-22 2022 /pmc/articles/PMC8608237/ /pubmed/34811648 http://dx.doi.org/10.1007/s12029-021-00751-6 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Research Yazici, Hilmi Eren, Ayse Uprak, Tevfik Kivilcim Sahan, Cihan Esmer, Ahmet Cem Yegen, Sevket Cumhur Gastric Cancer Surgery During the Pandemic: What It Costs? |
title | Gastric Cancer Surgery During the Pandemic: What It Costs? |
title_full | Gastric Cancer Surgery During the Pandemic: What It Costs? |
title_fullStr | Gastric Cancer Surgery During the Pandemic: What It Costs? |
title_full_unstemmed | Gastric Cancer Surgery During the Pandemic: What It Costs? |
title_short | Gastric Cancer Surgery During the Pandemic: What It Costs? |
title_sort | gastric cancer surgery during the pandemic: what it costs? |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608237/ https://www.ncbi.nlm.nih.gov/pubmed/34811648 http://dx.doi.org/10.1007/s12029-021-00751-6 |
work_keys_str_mv | AT yazicihilmi gastriccancersurgeryduringthepandemicwhatitcosts AT erenayse gastriccancersurgeryduringthepandemicwhatitcosts AT upraktevfikkivilcim gastriccancersurgeryduringthepandemicwhatitcosts AT sahancihan gastriccancersurgeryduringthepandemicwhatitcosts AT esmerahmetcem gastriccancersurgeryduringthepandemicwhatitcosts AT yegensevketcumhur gastriccancersurgeryduringthepandemicwhatitcosts |